MIRA
INFORM REPORT
|
Report Date : |
17.04.2007 |
IDENTIFICATION
DETAILS
|
Name : |
HARMANN PHARMACEUTICAL LABORATORIES (PRIVATE) LIMITED |
|
|
|
|
Registered Office : |
P. O. Chung, 16 KM
Multan Road, Lahore |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
1991 |
|
|
|
|
Com. Reg. No.: |
L - 04094/19911002 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture &
Marketing of Pharmaceutical Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Business Name
HARMANN PHARMACEUTICAL LABORATORIES (PRIVATE) LIMITED
Full Address
|
Registered Address
& Factory |
|
P.O.Chung, 16 KM
Multan Road, Lahore, Pakistan |
|
Tel |
92 (42) 7510778,
7510590 |
|
Fax |
92 (42) 7510448 |
|
|
Short Description Of
Business
|
Nature of Business |
Manufacture & Marketing of Pharmaceutical Products |
|
Year Established |
1991 |
|
Registration # |
L-04094/19911002 |
Branches
In Karachi & Islamabad
Auditors
Ayub Aslam & Co.
(Chartered
Accountants)
10-C-II, M.M. Alam Road, Gulberg III, Lahore, Pakistan
Legal Status
Subject Company was incorporated as a Private Limited Company in 1991
|
Authorised Capital |
Rs. 50,000,000/-
divided into 500,000 shares of Rs. 100/- each |
|
Issued & Paid up Capital |
Rs. 11,287,000/-
divided into 112,870 shares of Rs. 100/- each |
Details of Directors
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Muhammad Haseeb Khan Mr. Muhammad Asif Mr. Muhammad Tahir Khan Mrs. Abida Begum Mrs. Uzma Mamoon Mrs. Roshi Asif Mrs. Balqees Haseeb |
Pakistani Pakistani Pakistani Pakistani Pakistani Pakistani Pakistani |
12-Nargis Block, Allama Iqbal Town, Lahore 12-Nargis Block, Allama Iqbal Town, Lahore 12-Nargis Block, Allama Iqbal Town, Lahore 12-Nargis Block, Allama Iqbal Town, Lahore 12-Nargis Block, Allama Iqbal Town, Lahore 12-Nargis Block, Allama Iqbal Town, Lahore 12-Nargis Block, Allama Iqbal Town, Lahore |
Business Business Business Business Business Business Business |
Chief Executive Director Director Director Director Director Director |
Shareholders
Names
Mr. Muhammad Haseeb Khan
Mr. Muhammad Asif
Mr. Muhammad Tahir Khan
Mrs. Abida Begum
Mrs. Uzma Mamoon
Mrs. Roshi Asif
Mrs. Balqees Haseeb
Associated Companies
None
Products
ALDRON, AMADOL, AMOXICILLIN CAPS, ATROPINE EYE-DROPS, AVILON, AZIROL, CEWEL, CHLOROQUINE INJ, CONADERM-N, COSMOX, CYNOTONE, DEXAMETHASONE INJ, DEXAMETHASONE TABS, DIAZEPAM TAB, DOMPEDONE, ECZIM-G, FENTON, FENZOL, FOZIL, KETOS, LACTOSEL, LYSOBEX, LYVIT, MAGRACIN, MEFLIN, METAFIN, METRONIDAZOLE SUSP, METRONIDAZOLE TABS, NAPGESIC, NOVOPAM, NYSTRIN, OXYTOCIN, PAXIN, PROTOGYL, RENOPRIL, ROSDOL, UNIHAEM, VITANOL, WOMAQ, XYLOGEL, ZAVIC
Note:
Wide range of products ranging from Cardiology, Anti-Infective,
Musulo-Skeletal, Metabolic, CNS, Respiratory, Women Health, Immunology,
Multivitamins and many more are under developmental phase.
Number of Employees
145 - 160
Annual Production
Volume
The capacity and production of the company’s plant is
indeterminable as it is multi-product and involves varying processes of
manufacture.
Annual Sales Volume
|
Year |
In Pak Rupees |
|
2005 |
100,000,000/- (Estimated) |
Trade Suppliers
(Foreign)
GUFIC BIOSCIENCES LIMITED, INDIA.
ZHEJIANG CHEMICAL IMPORT & EXPORT CORPORATION, CHINA.
AARTI DRUGS, INDIA.
ASHU INTERNATIONAL, INDIA.
SHIJIAHUANG CHEM PHARM, CHINA.
Customers
Mainly Pharmacies, Distributors, Hospitals & Trading Companies.
Exporting Countries
Mainly to Srilanka, Nepal and African Countries.
Bankers and their
addresses
Soneri Bank Limited, Main Branch, Shahrah-e-Quaid-e-Azam, Lahore, Pakistan
Foreign Exchange
Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 60.76 |
|
UK Pound |
1 |
Rs. 120.55 |
|
Euro |
1 |
Rs. 82.00 |
Comments
Subject Company was established in 1991 and is engaged in manufacture & marketing of Pharmaceutical Products. Directors are reported as resourceful and experienced businessmen. Trade relations are reported as fair. The Company can be considered for normal business dealings at usual trade terms and conditions.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)